Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Acquisition of BioSpin Clears Antitrust Period; Shareholders' Meeting Scheduled

NEW YORK (GenomeWeb News) – Bruker BioSciences said today that the Hart-Scott-Rodino waiting period for its proposed acquisition of affiliate Bruker BioSpin has expired.
 
Bruker BioSciences announced in early December that it had launched a $914 million takeover of Bruker BioSpin, which is 100 percent owned by members of the Laukien family, who also own 52 percent of publicly traded Bruker BioSciences.
 
Bruker also said today that it has scheduled a special meeting of its stockholders on Feb. 25 to vote on the proposed acquisition. Shareholders of record as of the close of business on Jan. 11 are eligible to vote on the transaction.
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.